BRAF mutations in conjunctival melanoma

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 8, 2004, Pages 2484-2488

  Gear, Heather ^a   Williams, Hawys ^b   Kemp, Ewan G ^a   Roberts, Fiona ^b  

^a GARTNAVEL GENERAL HOSPITAL   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAF GENE; CANCER INVASION; CLINICAL ARTICLE; CONJUNCTIVA MELANOMA; CONJUNCTIVA TUMOR; CORRELATION ANALYSIS; DNA EXTRACTION; FEMALE; GENE; GENE MUTATION; HUMAN; HUMAN TISSUE; MALE; MELANOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PURIFICATION; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; CONJUNCTIVAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA, NEOPLASM; HUMANS; MELANOMA; MIDDLE AGED; MUTATION; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS B-RAF; PROTO-ONCOGENE PROTEINS C-RAF; SKIN NEOPLASMS;

EID: 3242881864     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-0093     Document Type: Article

References (30)

1. Folberg R. Melanocytic lesions of the conjunctiva. In: Spencer S, ed. Ophthalmic Pathology. Philadelphia: WB Saunders; 1996:125-155.
2. Guo-Pei Y, Dan-Nin H, McCormick S, Finger PT. Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol. 2003;135:800-806.
3. McCarthy JM, Rootman J, Horsman D, White VA. Conjunctival and uveal melanoma in the dysplastic nevus syndrome. Surv Ophthalmol. 1993;37:377-386.
4. Aoyagi M, Morishima N, Yoshino Y, et al. Conjunctival malignant melanoma with xeroderma pigmentosum. Ophthalmologica. 1993;206:162-167.
5. To KW, Rabinowitz SM, Friedman AH, Merker C, Cavanaugh CP. Neurofibromatosis and neural crest neoplasms: primary acquired melanosis and malignant melanoma of the conjunctiva. Surv Ophthalmol. 1989;33:373-379.
6. Silvers D, Jakobiec FA, Freeman T, et al. Melanoma of the conjunctiva: a clinicopathologic study. In: Jakobiec FA, ed. Ocular and Adnexal Tumors. Birmingham, UK: Aesculapius; 1978:583-599.
7. Kolch W. Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J. 2000;351:289-305.
8. Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417:949-954.
9. Cohen U, Goldenberg-Cohen N, Parrella P, et al. Lack of BRAF mutation in primary uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:2876-2878.
10. Cruz F, Rubin BP, Wilson D, et al. Absence of BRAF and NRAS mutations in uveal melanoma. Cancer Res. 2003;63:5761-5766.
11. Edmunds SC, Cree IA, Di Nicolantonio F, Hungerford JL, Hurren JS, Kelsell DP. Absence of BRAF gene mutations in uveal melanomas in contrast to cutaneous melanomas. Br J Cancer. 2003;88:1403-1405.
12. Rimoldi D, Salvi S, Lienard D, et al. Lack of BRAF mutations in uveal melanoma. Cancer Res. 2003;63:5712-5715.
13. Farber M, Schutzer P, Mihm MCJ. Pigmented lesions of the conjunctiva. J Am Acad Dermatol. 1998;38:971-978.
14. Seregard S. Conjunctival melanoma. Surv Ophthalmol. 1998;42:321-350.
15. Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N, Steuhl K-P. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol. 2002;86:163-167.
16. Shields CL, Shields JA, Gunduz K, et al. Conjunctival melanoma: risk factors for recurrence exenteration, metastasis and death in 150 consecutive patients. Arch Ophthalmol. 2000;118:1497-1507.
17. Pollock PM, Meltzer PS. A genome-based strategy uncovers frequent BRAF mutations in melanoma. Cancer Cell. 2002;2:5-7.
18. Brose MS, Volpe P, Feldman M, et al. BRAF and RAS mutations in human lung cancer and melanoma. Cancer Res. 2002;62:6997-7000.
19. Pollock PM, Harper UL, Hansen KS, et al. High frequency of BRAF mutations in nevi. Nat Genet. 2003;33:19-20.
20. Calipel A, Lefevre G, Pouponnot C, Mouriauz F, Eychene A, Mascarelli F. Mutation of B-Raf in human choroidal melanoma cells mediates cell proliferation and transformation through the MEK/ERK pathway. J Biol Chem. 2003;43:42409-42418.
21. Noden DM. Periocular mesenchyme: neural crest and mesodermal interactions. In: Jakobiec FA, ed. Ocular Anatomy, Embryology and Teratology. Philadelphia: Harper & Row; 1982:97-119.
22. Hogan MJ, Alvarado JA, Weddell JE. Histology of the Human Eye: an Atlas and Textbook. Philadelphia: WB Saunders; 1971:202-392.
23. McLean IW, Foster WD, Zimmermann LE. Uveal melanoma: location, size, cell type, and enucleation as risk factors in metastasis. Hum Pathol. 1982;13:123-132.
24. Iwamoto S, Burrows RC, Grossniklaus HE, et al. Immunophenotype of conjunctival melanomas: comparison with uveal and cutaneous melanomas. Arch Ophthalmol. 2002;120:1625-1629.
25. Jakobiec FA, Folberg R, Iwamoto S. Clinicopathologic characteristics of premalignant and malignant melanocytic lesions of the conjunctiva. Ophthalmology. 1989;96:147-166.
26. Tuomaala S, Kivela T. Conjunctival melanoma: is it increasing in the United States? Am J Ophthalmol. 2003;136:1189-1190.
27. Maldonado JL, Fridlyand J, Patel H, et al. Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst. 2003;17:1878-1890.
28. Shinozaki M, Fujimoto A, Morton DL, Hoon DSB. Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas. Clin Cancer Res. 2004;10:1753-1757.
29. Bollag G, Freeman S, Lyons JF, Post LE. Raf pathway inhibitors in oncology. Curr Opin Invest Drugs. 2003;12:1436-1441.
30. Tuveson DA, Weber BL, Herlyn M. BRAF as a potential therapeutic target in melanoma and other malignancies. Cancer Cell. 2003;4:95-98.